5 Cell and Gene Therapy Decisions to Watch in 2024 | BioSpace
https://www.biospace.com/article/5-cell-and-gene-therapy-decisions-to-watch-in-2024/
WEB3 days ago · Here, BioSpace reviews five products under regulatory review that were highlighted by both organizations. Pfizer’s Beqvez. Indication: Hemophilia B. Therapy type: In vivo gene therapy. Action date: April 27. Later this month, the FDA will rule on Pfizer’s gene therapy for hemophilia B, Beqvez. This engineered version of the factor IX ...
DA: 73 PA: 2 MOZ Rank: 86